VERTEX PHARMACEUTICALS INC / MA Deferred Tax Liabilities, Net, Noncurrent
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Deferred Tax Liabilities, Net, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-02-13.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-02-13
- 2018-12-31: Deferred Tax Liabilities, Net, Noncurrent $0.00.
- 2018-06-30: Deferred Tax Liabilities, Net, Noncurrent $9.34M.
- 2018-03-31: Deferred Tax Liabilities, Net, Noncurrent $9.64M.
- 2017-12-31: Deferred Tax Liabilities, Net, Noncurrent $6.34M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-13 |
| 2018-06-30 | $9.34M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $9.64M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $6.34M 10-K · filed 2019-02-13 |
| 2017-09-30 | $10.68M 10-Q · filed 2017-10-30 |
| 2017-06-30 | $136.65M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $135.40M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $134.06M 10-K · filed 2018-02-15 |
| 2016-09-30 | $133.27M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $132.81M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $112.26M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $110.44M 10-K · filed 2017-02-23 |
| 2015-09-30 | $113.86M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $112.41M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $15.09M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $15.04M 10-K · filed 2016-02-16 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |
| 2013-09-30 | $150.20M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $149.71M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $151.66M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $280.37M 10-K · filed 2014-02-11 |
| 2012-09-30 | $279.47M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $263.02M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $241.43M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $243.71M 10-K · filed 2013-03-01 |
| 2011-09-30 | $231.18M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $260.45M 10-Q · filed 2011-08-09 |
| 2011-03-31 | $160.28M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $160.28M 10-K · filed 2012-02-22 |
| 2010-09-30 | $160.28M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $160.28M 10-Q · filed 2010-08-03 |
| 2010-03-31 | $160.28M 10-Q · filed 2010-05-03 |
| 2009-12-31 | $160.28M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |